Durata Therapeutics Announces NDA Submission for Dalbavancin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) CHICAGO, Sept. 26, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX), an emerging specialty...
Treato Expands US Presence and Leadership Team with New Senior Executive Hires Healthcare Industry Veterans, Ezra Ernst and Gerhard Gallwitz, Join Treato Management Team to Accelerate Company US Growth YEHUD, Israel, October 2, 2013 /PRNewswire/ — Treato, the...
Durata Therapeutics Presents New Comprehensive Review of the Efficacy and Safety Data of Dalbavancin and New In Vitro Findings at IDWeek 2013™ SAN FRANCISCO, Oct. 2, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced a comprehensive...
TigerText Goes Freemium; Launches Next Generation of its Secure Enterprise Messaging App for BYOD Fourth-generation TigerText app allows anyone to instantly create their own enterprise messaging mobile network; More than 10,000 businesses already signed up. SANTA...
Chimerix Announces Proposed Public Offering of Common Stock All Shares to be Sold by Existing Shareholders DURHAM, N.C., Oct. 8, 2013 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high...
Recent Comments